The world first started to hear about a novel coronavirus in early January 2020, with reports of an alleged new pneumonia-like illness spreading across Wuhan, China.
The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.
Two children were hospitalized at Le Bonheur Children’s Hospital in Tennessee after their parents couldn’t find a special type of baby formula amid a nationwide shortage, according to a local doctor.
"I've heard people say it's common sense (to get vaccinated), but what about all the other countries that have taken it and still put people in lockdown," says local Ghanaian.
The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot.